CIO

MARCH 24, 2023

Perhaps most important, Idorsia taps into Veeva’s evolving knowledge base, which encompasses data from other customers such as major pharmaceuticals giants Merck, Bayer, and Kronos, the CIO says. And that is a major gain for a startup — getting the know-how and experience of Veeva’s entire customer base, he says.

Business 414

Business Pharmaceutical Startups Value Chain 414

CIO

JUNE 5, 2023

The pharmaceutical industry is a highly regulated one, especially for multinationals doing business across the globe. Although non-compliance with regulations can attract exorbitant fines, many pharma companies still depend on manual process for these value chains.

Banking 368

Banking Pharmaceutical Value Chain Human Resources 368

Smart Data Collective

JANUARY 11, 2021

So, by utilizing cloud technology, you can ensure your machines have less downtime, which helps business continuity. The cloud also supports manufacturers’ integration into global supply, production, and value chains. Supports Manufacturing Supply Chain Integration. Such things are automatically taken care of.

Pharmaceutical 253

Pharmaceutical Value Chain Market Research Marketing Research 253

Evalueserve

DECEMBER 6, 2021

High uncertainty about the business being acquired given shrinking valuations post De-SPAC. With the spotlight been on enhancing scale and resilience of business portfolios, companies and investment firms have rushed to get ahead of the potential changes in healthcare delivery. Key Market Restraints: .

Capital 98

Capital Globalization Biotech Marketing 98

Timo Elliot

DECEMBER 6, 2024

Axial: The Strategic Backbone for Bold Ambition 2030 An overview of the Axial program At the heart of AstraZeneca’s Bold Ambition 2030 lies “Axial”, an ambitious initiative to modernize its operations and propel the pharmaceutical giant toward industry leadership.

Innovation 52

Innovation Pharmaceutical Value Chain Globalization 52

Evalueserve

MARCH 23, 2021

In the long-term, this function is poised to be disrupted through newer technologies and business models. Technologies such as block-chain and business models like Amazon B2B are just a few examples of what companies are experimenting with. Sustainability continues to be the critical mega trend in this sector.

Intelligence 52

Intelligence Intelligence Pharmaceutical Value Chain 52

Alpha Sense BI

APRIL 12, 2024

Although, they’re trying to make TPU as a more open framework.” – Former Head of Engineering, Google | Expert Transcript When a pharmaceutical company launches a new drug, how do you know if the benefits to patients outweigh the side effects and costs? The value chain is a little different in tech.

Primary Research 52

Primary Research Advantage Advantage Research 52